Forefront Wealth Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$930K Buy
775
+4
+0.5% +$4.09K 0.29% 80
2026
Q1
$709K Buy
771
+40
+5% +$40.6K 0.3% 75
2025
Q4
$786K Sell
731
-10
-1% -$9.56K 0.37% 62
2025
Q3
$566K Buy
741
+193
+35% +$144K 0.14% 121
2025
Q2
$423K Sell
548
-105
-16% -$81.6K 0.29% 68
2025
Q1
$539K Buy
653
+105
+19% +$87.4K 0.37% 64
2024
Q4
$423K Buy
+548
New +$454K 0.32% 65

Other funds holding LLY

Forefront Wealth Partners's LLY Position: Q2 2026 in Review

Forefront Wealth Partners increased its Eli Lilly (LLY) stake by 0.52% in Q2 2026, buying an estimated $4.09K and bringing the position to 775 shares worth $930K. The position accounts for 0.29% of the portfolio, ranked #80.

Forefront Wealth Partners first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Forefront Wealth Partners held 775 shares of Eli Lilly worth $930K as of Q2 2026.
  • Forefront Wealth Partners bought 4 Eli Lilly shares in Q2 2026, an estimated $4.09K.
  • Eli Lilly made up 0.29% of Forefront Wealth Partners's portfolio in Q2 2026, its #80 holding.
  • Forefront Wealth Partners first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Forefront Wealth Partners's 13F filing for Q2 2026, filed 20 Aug 2026.